Lonza | LONN - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Akzo Nobel EUR 254M 37M 2026-03
Alcon AG USD 297M 16M 2026-03
Almirall EUR 30.23M 12.8M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
BASF EUR 1.4B 1.58B 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Beiersdorf EUR 504M 312M 2025-12
Covestro EUR -324M 5.72B 2025-12
Demant DKK 2.09B 224M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
Geberit CHF 134.1M 65.8M 2025-12
Genmab DKK 260M 199M 2025-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GN Store Nord DKK -68M 638M 2026-03
Hikma Pharmaceutical USD 348M 161M 2025-12
Johnson Matthey GBP 142M 89M 2025-12
Merck EUR 1.05B 572M 2026-03
Novartis USD 4.24B 171M 2026-03
Philips EUR 302M 417M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sika AG CHF 724.9M 73.2M 2025-12
Smith & Nephew USD 440M 50M 2025-12
Solvay EUR 118M 58M 2026-03
UCB EUR 1.29B 571M 2025-12